Colorectal Cancer Statistics in Virginia - Maps. July

Similar documents
Lung and Bronchus Cancer Statistics in Virginia - Maps. July

Diet, Physical Activity, Weight & Cancer Survivorship: Perspectives from the NCI

Overview of All SEER-Medicare Publications

Healthcare Reform and Cancer Survivorship: Implications for Care & Research

Cancer of the Breast (Female) - Cancer Stat Facts

Percent Surviving 5 Years 89.4%

Early Detection: Screening Guidelines

Breast Cancer Survivorship: Physical Activity

Improving Representation of Diverse Patients in Clinical Trials

The ACA and Breast Cancer: Danger for Disparities Still Exists, Despite Law s Intentions

Trends in Oncology Care. Challenges and Obstacles. Lawrence N. Shulman, MD Dana-Farber Cancer Institute Brigham and Women s Hospital

Mercy s 2013 Cancer Program Annual Report

1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL

Head and neck cancer disparities, Genetics, Environment, Behavior: What really matters?

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health

What Is Small Cell Lung Cancer?

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer

South Asian Journal of Engineering and Technology Vol.3, No.9 (2017) 17 22

National Center for Health and the Aging

Kidney Cancer Causes, Risk Factors, and Prevention

What Is Cancer of the Esophagus?

in Women ages Whitney Stilwell Health 240: Section 002 Clemson University

Chapter 13 Cancer of the Female Breast

Esophagus Cancer Causes, Risk Factors, and Prevention

An Overview of Survival Statistics in SEER*Stat

Distribution and evaluation of primary bone and soft tissue tumors admitted from Malatya province and surrounding provinces

Decline and Disparities in Mammography Use Trends by Socioeconomic Status and Race/Ethnicity

Accepted Manuscript. Utility of Genetic Testing in Persons with Multiple Colorectal Polyps. Natalia Khalaf, MD, MPH, Niloy Jewel Samadder, MD, MS

Robot-Assisted Radical Prostatectomy

CDC Programmatic Activities in Breast and Ovarian Cancer Genomics

Colorectal Cancer in Idaho November 2, 2006 Chris Johnson, CDRI

Metropolitan and Micropolitan Statistical Area Cancer Incidence: Late Stage Diagnoses for Cancers Amenable to Screening, Idaho

Surveillance Mammography Among Female Department of Defense Beneficiaries

Hepatocellular carcinoma (HCC) incidence

Childhood Cancer Survivor Study Analysis Concept Proposal. Title: Analysis of Late Mortality by Treatment Era.

Per Capita Health Care Spending on Diabetes:

Chronic Disease Challenges and Solutions

Pancreatic Cancer Incidence, Mortality, and Survival in the SEER 17 Southern and Total United States ( )

Drug Overdose Deaths in the United States,

Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women

Cancer Related Fatigue Dan 1. The Effects that Non-steroidal Anti-inflammatory Drugs (NSAID) have on Cancer Related Fatigue in a Mouse Model

Chapter 23 Cancer of the Urinary Bladder

Cancer in North America: Volume One: Combined Cancer Incidence for the United States, Canada, and North America

Downloaded from jps.ajaums.ac.ir at 19: on Friday March 22nd 2019

Yakutat Cancer Study

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Adjuvant Multi-agent Chemotherapy and Tamoxifen Usage Trends for Breast Cancer in the United States

National Cancer Statistics in Korea, 2014

The State of Asthma in Arkansas

Diabetes mellitus increases risk for colorectal adenomas in younger patients

NEZ PERCE COUNTY CANCER PROFILE

KOOTENAI COUNTY CANCER PROFILE

BOUNDARY COUNTY CANCER PROFILE

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

ADAMS COUNTY CANCER PROFILE

BONNER COUNTY CANCER PROFILE

Understanding Breast Cancer Rates

Cancer Treatment for Dual Eligibles: What Are the Costs and Who Pays?

NIH Public Access Author Manuscript Mil Med. Author manuscript; available in PMC 2013 June 01.

Annual Report to the Nation on the Status of Cancer, , Featuring the Increasing Incidence of Liver Cancer

Hysterectomy-Corrected Rates of Endometrial Cancer among Women of Reproductive Age

Overview from the Division of Cancer Prevention and Control

Abstract. Duggan et al. BMC Cancer 2012, 12:170

This proposal will be set within the Chronic Disease and Cancer Control Working Groups.

Issue Brief. Wisconsin Cancer Council. The Increasing Burden of Liver Cancer in Wisconsin KEY POINTS. Introduction. AUGUST 2018 Volume 13 Number 1

The Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

THE DECLINE IN CERVICAL CANCER incidence

ASTHMA BY RACE AND ETHNICITY

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure

Trends in Emergency Department Visits for Ischemic Stroke and Transient Ischemic Attack: United States,

Incidence-based Mortality Method to Partition Tumor-Specific Mortality Trends: Application to Non-Hodgkin Lymphoma Cancer

Using Data from the Cancer Genome Atlas to Investigate Molecular Events Related to Ovarian Cancer. Abstract

Distribution of breast cancer stage at diagnosis and socioeconomic status in Oregon

EARLY DETECTION: AN OPPORTUNITY FOR CANCER PREVENTION THROUGH EARLY INTERVENTION. (Abridged) D. James Morré and Dorothy M. Morré

Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea,

Lymphedema In Ovarian Cancer Survivors: Assessing Diagnostic Methods And Risk Factors

Cancer in North America: Volume Three: Registry-specific Cancer Mortality in the United States

Anti-Neoplastic Effects of Extracts from Gnaphalium gracile on Colon, Pancreatic, and Prostate Cancer Cells

Cancer Statistics, 2008

Today s Presentation ABOUT US. Herna Joy Gonzalez, RN, BSN, MS, CCRP

Image Segmentation of Blood Cells in Leukemia Patients

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score

Cancer in North America: Volume One: Combined Cancer Incidence for the United States, Canada, and North America

MORTALITY AFTER METASTATIC BREAST CANCER: CO-MORBIDITY AS A MEDIATOR OF AGE ON SURVIVAL, AND DELAYS IN TREATMENT FOR BREAST CANCER METASTASIS

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation

Using Cancer Registry Data for Post Marketing Surveillance of Rare Cancers

Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes

VENTANA MMR IHC Panel Interpretation Guide for Staining of Colorectal Tissue

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Care for Children and Adolescents With Cancer: Questions and Answers. Key Points

Cancer in North America: Volume Three: Registry-specific Cancer Mortality in the United States and Canada

CANCER IN IDAHO 2016 Preliminary

Impact of health care insurance on overall survival of patients with multiple myeloma and monoclonal gammopathy of undetermined significance

Stomach Cancer Early Detection, Diagnosis, and Staging

Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview

Transcription:

July 2011 5

July 2011 6

July 2011 7

July 2011 8

Colorectal Cancer Statistics in Virginia - Notes Sources: Incidence and percent local staging (VA Cancer Registry); mortality (VDH Division of Health Statistics); risk factor prevalence (Behavioral Risk Factor Surveillance System). 1 Based on combined 2004-2008 data. Rates are age- adjusted to the 2000 U.S. standard population. Districts are ranked in terms of incidence rates from highest (=1) to lowest (=35). Districts with lower rankings (i.e. higher incidence rates) are at greater risk. Source for national rate: Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011. Based on combined data from 2004-2008. Rates are age-adjusted to the 2000 U.S. standard population. 2 Based on combined 2004-2008 data. Percentage of Local Stage cancers are reported using the Summary Staging System. Districts are ranked in terms of percentage of cases diagnosed early (local) from lowest (=1) to highest (=35). Districts with lower rankings (i.e. lower early stage percentages) are at greater risk. Source for national average: Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011. Based on combined data from 2001-2007. 3 Based on combined 2005-2009 data. Rates are age- adjusted to the 2000 U.S. standard population. Districts are ranked in terms of mortality rates from highest (=1) to lowest (=35). Districts with lower rankings (i.e. higher mortality rates) are at greater risk. Source for national rate: Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. National rate is the 2007 age-adjusted rate, which is comparable to the state five-year interval midpoint. 4 Behavioral Risk Factor Surveillance System is a national telephone survey of adults 18+. District estimates are based on 2006 and 2008 (pooled) data. Percentages are population-weighted. Source for state and national prevalence estimates: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available from: http://apps.nccd.cdc.gov/brfss. Accessed 6/2/10. State and national numbers are based on 2008 data. Colorectal Cancer Screening: Lifetime endoscopy = Percentage of adults age 50 years and older reporting ever having a sigmoidoscopy/colonoscopy during their lifetime; Blood stool test = Percentage of adults age 50 years and older reporting stool hemoccult (blood stool) test within past two years; Colorectal cancer screening (comb.) = Percentage of adults 50 and older who had a sigmoidoscopy/colonoscopy within the past 5 years and/or a home blood stool test within the past year. Districts are ranked in terms of prevalence of colorectal cancer screening from lowest (=1) to highest (=35). District with lower rankings (i.e. lower colorectal cancer screening prevalence) are at greater risk. Rankings are based on colorectal cancer screening (comb.) 5 Summary score is computed by adding rank score for incidence, local staging, mortality and screening prevalence. Lower score indicates higher risk. Top five districts with the highest risk (i.e. lowest rank) are highlighted. Maps illustrate rates or percentages in quantiles. This publication was supported by the Cooperative Agreement Number #5U58DP000780 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the Centers for Disease Control and Prevention. July 2011 9